IRIS
BARRECA, Maria Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.642
EU - Europa 3.300
AS - Asia 1.673
SA - Sud America 502
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 41
OC - Oceania 3
Totale 13.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.560
RU - Federazione Russa 1.685
SG - Singapore 672
CN - Cina 501
BR - Brasile 437
IE - Irlanda 374
SE - Svezia 329
UA - Ucraina 284
HK - Hong Kong 180
DE - Germania 173
VN - Vietnam 162
GB - Regno Unito 130
FI - Finlandia 82
FR - Francia 76
IT - Italia 62
CA - Canada 46
IN - India 41
AR - Argentina 28
MX - Messico 23
CZ - Repubblica Ceca 18
PL - Polonia 16
BD - Bangladesh 15
IQ - Iraq 15
TR - Turchia 15
BE - Belgio 14
NL - Olanda 12
EC - Ecuador 11
ZA - Sudafrica 11
PK - Pakistan 10
UZ - Uzbekistan 10
ES - Italia 9
TN - Tunisia 8
VE - Venezuela 8
EG - Egitto 6
IR - Iran 6
JP - Giappone 6
CI - Costa d'Avorio 5
CO - Colombia 5
HN - Honduras 5
ID - Indonesia 5
IL - Israele 5
MA - Marocco 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CL - Cile 4
LT - Lituania 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
GR - Grecia 3
GT - Guatemala 3
KE - Kenya 3
PE - Perù 3
CY - Cipro 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 13.164
Salva come PNG Salva come JPEG
Città #
Dallas 4.546
Moscow 496
Jacksonville 488
Singapore 392
Dublin 374
Chandler 364
Ashburn 304
Nyköping 224
Hong Kong 180
Beijing 175
Council Bluffs 147
San Jose 140
Dong Ket 115
Los Angeles 91
The Dalles 77
Princeton 75
Cambridge 73
Medford 71
Lauterbourg 61
Des Moines 58
Boardman 50
Columbus 47
Dearborn 41
Buffalo 38
Lancaster 28
São Paulo 28
Ann Arbor 27
Woodbridge 27
Tianjin 23
Chicago 19
Guangzhou 19
Wilmington 19
Brno 18
Nanjing 18
Jinan 16
New York 16
Rio de Janeiro 16
Belo Horizonte 15
Haikou 15
Ho Chi Minh City 15
Santa Clara 15
Brussels 14
Munich 14
Ottawa 14
Brooklyn 13
London 13
Warsaw 13
Hebei 12
Hyderabad 12
Orem 12
Washington 12
Hanoi 11
Shenyang 11
Taizhou 11
Montreal 10
Saint Petersburg 10
Seattle 10
Amsterdam 9
Atlanta 9
Frankfurt am Main 9
Milan 9
Pune 9
San Mateo 9
Tashkent 9
Zhengzhou 9
Manchester 8
Phoenix 8
San Francisco 8
Brasília 7
Campinas 7
Curitiba 7
Denver 7
Hangzhou 7
Norwalk 7
Poplar 7
Santo André 7
Stockholm 7
Auburn Hills 6
Baghdad 6
Istanbul 6
Johannesburg 6
Leawood 6
Mexico City 6
Tokyo 6
Toronto 6
Tunis 6
Abidjan 5
Ardabil 5
Campo Grande 5
Dhaka 5
Fuzhou 5
Houston 5
Lahore 5
Redondo Beach 5
Riva 5
Shanghai 5
Shenzhen 5
St Petersburg 5
Taiyuan 5
Boston 4
Totale 9.435
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.616
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 284
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 253
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 189
Anti-HIV agents: design and discovery of new potent RT inhibitors 175
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 174
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 166
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 160
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 159
Binding modes of noncompetitive AMPA antagonists: a computational approach 156
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 155
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 155
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 149
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 149
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 147
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 140
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 139
Computational studies of inhibitor resistance in HIV-1 integrase 139
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 137
Efficient 3D Database screening for novel HIV-1 IN inhibitors 137
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 136
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 131
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 130
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 128
Synthesis of new potential HIV-1 integrase inhibitors 126
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 120
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 115
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 112
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 111
Dynamic pharmacophore model development and testing 110
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 110
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 109
Design and Synthesis of NR2B Subtype-Selective Antagonist 109
Design and synthesis of new HIV-1 NNRTIs 108
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 108
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 105
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 103
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 103
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 102
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 102
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 102
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 102
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 101
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 100
New trends in the development of AMPA receptor antagonists 100
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 100
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 100
Molecular dynamics studies of the full-length integrase-DNA complex 98
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 98
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 92
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 92
Molecular dynamics studies of the HIV-1 integrase 91
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 91
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 89
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 89
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 89
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 89
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 88
Discovery of novel HIV-1 integrase inhibitors through computational strategies 88
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 87
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 86
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 86
Pharmacophore-based design of HIV-1 integrase inhibitors 85
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 84
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 83
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 83
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 82
Rational design and synthesis of novel NNRTI TBZ analogues 82
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 82
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 79
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 78
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 64
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 58
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 35
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 35
null 28
null 27
null 27
null 25
null 25
null 24
Prion protein ligands as therapeutic agents for neurodegenerative disorders 11
Totale 13.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/20251.226 20 35 49 101 14 44 16 289 321 52 84 201
2025/20267.880 131 1.471 3.216 304 269 917 500 417 440 120 66 29
2026/2027312 71 241 0 0 0 0 0 0 0 0 0 0
Totale 13.212